Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Acute Haemodialysis, Haemodynamically Instable Patients and Chronic Haemodialysis Patients

Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY

Retrospective analysis of performance and treatment data collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter \& Genius 90 Concentrates in acute haemodialysis, haemodynamically instable patients and chronic haemodialysis patients * to analyse performance and treatment data from patients treated with the investigational device * to evaluate the filter characteristics for aHD (Acute haemodialysis) patients * to evaluate the improvement of kidney function for aHD patients

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• All patients with an indication for the extracorporeal blood treatment suffering from renal insufficiency who received all treatments, between January 2019 and December 2019, with the investigational devices have to be included in the study in chronological order.

• For aHD patients: availability of at least 3 of the 5 primary variables (daily urea, creatinine, potassium, ultrafiltration and effluent volume) for 50 % of the documented treatments.

• For cHD patients: availability of the ultrafiltration values for all treatments and at least one value for urea and creatinine per week

Locations
Other Locations
Germany
Medizinische Hochschule Hannover
RECRUITING
Hanover
Universitätsklinikum Jena
RECRUITING
Jena
Contact Information
Primary
Tatiana De los Rios
Tatiana.De-Los-Rios@fmc-ag.com
+49 6172 608 2362
Backup
Jana Schmitt
Jana.Schmitt@fmc-ag.com
+49 6172 609 95403
Time Frame
Start Date: 2022-10-07
Estimated Completion Date: 2025-12
Participants
Target number of participants: 100
Treatments
aHD: Acute haemodialysis patients
cHD: Chronic haemodialysis patients
Authors
Carsten Sanft
Related Therapeutic Areas
Sponsors
Collaborators: Alcedis GmbH
Leads: Fresenius Medical Care Deutschland GmbH

This content was sourced from clinicaltrials.gov